Olgu Sunumu
BibTex RIS Kaynak Göster

ARTERIAL AND VENOUS EMBOLISM DUE TO COVID-19 VACCINE (BIONTECH): CASE SERIES

Yıl 2022, Cilt: 13 Sayı: 3, 79 - 81, 30.09.2022
https://doi.org/10.33706/jemcr.1089785

Öz

Introduction: Although the most prominent effect of Corona disease, respiratory disease it disrupts the vascular structure and causes vascular occlusion. Intravascular coagulation, has also begun to be observed in people who have been vaccinated. Therefore, clinicians had to add anti-coagulants or antiaggregants to the treatment.
Case Reports: In this article; We will try to present the patient who developed arterial and venous embolism after BioNTech vaccine. These patients without known vascular disease responded well to treatment.
Conclusion: The rate of sickness dropped after the vaccine was discovered to be the most effective strategy to protect against Covid-19. It was discovered that vaccinated patients exhibited symptoms similar to corona disease but had a moderate course.

Kaynakça

  • Referans1 Çelik H, Saadoon AQ. COVID-19 with pulmonary embolism: Case report. Cumhuriyet Medical Journal 2020; 42(2), 213-215.
  • Referans2 Makhoul K, Shukha Y, Hanna LA, Nitecki S, Leiderman M, Hayek T, et. al. A case of rapidly progressive upper limb ischemic necrosis in a patient with COVID-19. International Journal of Infectious Diseases 2021; 106, 401-404.
  • Referans3 T.C. Sağlık Bakanlığı-COVID-19-Bilgilendirme Platformu. https://covid19.saglik.gov.tr/TR-66341/antisitokin-antiinflamatuar-tedaviler-koagulopati-yonetimi. Access:1.2.22
  • Referans4 Wikipedia the free encyclopedia. https://tr.wikipedia.org/COVID-19 vaccination in Turkey. Access: 30.1.22
  • Referans5 Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. Journal of thrombosis and haemostasis 2020; 18(4), 844-847.
  • Referans6 Schultz NH, Sørvoll IH, Michelsen AE, Munthe LA, Lund-Johansen F, Ahlen MT, et. al. Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination. New England journal of medicine 2021; 384(22), 2124-2130.
  • Referans7 Smadja DM, Yue QY, Chocron R, Sanchez O, Lillo-Le Louet A. Vaccination against COVID-19: Insight from arterial and venous thrombosis occurrence using data from VigiBase. European Respiratory Journal 2021.
  • Referans8 Tissot N, Brunel AS, Bozon F, Rosolen B, Chirouze C, Bouiller K. Patients with history of covid-19 had more side effects after the first dose of covid-19 vaccine. Vaccine 2021; 39(36), 5087-5090.
  • Referans9 Spyropoulos AC, Levy JH, Ageno W, Connors JM, Hunt BJ, Iba T, et. al. Scientific and standardization committee communication: Clinical guidance on the diagnosis, prevention and treatment of venous thromboembolism in hospitalized patients with COVID-19. J ThrombHaemost 2020
  • Referans10 Elnaem MH, MohdTaufek NH, Ab Rahman NS, MohdNazar NI, Zin CS, Nuffer W, et. al. COVID-19 Vaccination Attitudes, Perceptions, and Side Effect Experiences in Malaysia: Do Age, Gender, and Vaccine Type Matter? Vaccines 2021; 9(10), 1156.
Yıl 2022, Cilt: 13 Sayı: 3, 79 - 81, 30.09.2022
https://doi.org/10.33706/jemcr.1089785

Öz

Kaynakça

  • Referans1 Çelik H, Saadoon AQ. COVID-19 with pulmonary embolism: Case report. Cumhuriyet Medical Journal 2020; 42(2), 213-215.
  • Referans2 Makhoul K, Shukha Y, Hanna LA, Nitecki S, Leiderman M, Hayek T, et. al. A case of rapidly progressive upper limb ischemic necrosis in a patient with COVID-19. International Journal of Infectious Diseases 2021; 106, 401-404.
  • Referans3 T.C. Sağlık Bakanlığı-COVID-19-Bilgilendirme Platformu. https://covid19.saglik.gov.tr/TR-66341/antisitokin-antiinflamatuar-tedaviler-koagulopati-yonetimi. Access:1.2.22
  • Referans4 Wikipedia the free encyclopedia. https://tr.wikipedia.org/COVID-19 vaccination in Turkey. Access: 30.1.22
  • Referans5 Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. Journal of thrombosis and haemostasis 2020; 18(4), 844-847.
  • Referans6 Schultz NH, Sørvoll IH, Michelsen AE, Munthe LA, Lund-Johansen F, Ahlen MT, et. al. Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination. New England journal of medicine 2021; 384(22), 2124-2130.
  • Referans7 Smadja DM, Yue QY, Chocron R, Sanchez O, Lillo-Le Louet A. Vaccination against COVID-19: Insight from arterial and venous thrombosis occurrence using data from VigiBase. European Respiratory Journal 2021.
  • Referans8 Tissot N, Brunel AS, Bozon F, Rosolen B, Chirouze C, Bouiller K. Patients with history of covid-19 had more side effects after the first dose of covid-19 vaccine. Vaccine 2021; 39(36), 5087-5090.
  • Referans9 Spyropoulos AC, Levy JH, Ageno W, Connors JM, Hunt BJ, Iba T, et. al. Scientific and standardization committee communication: Clinical guidance on the diagnosis, prevention and treatment of venous thromboembolism in hospitalized patients with COVID-19. J ThrombHaemost 2020
  • Referans10 Elnaem MH, MohdTaufek NH, Ab Rahman NS, MohdNazar NI, Zin CS, Nuffer W, et. al. COVID-19 Vaccination Attitudes, Perceptions, and Side Effect Experiences in Malaysia: Do Age, Gender, and Vaccine Type Matter? Vaccines 2021; 9(10), 1156.
Toplam 10 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Klinik Tıp Bilimleri
Bölüm Case Report
Yazarlar

Oya Güven 0000-0002-6389-4561

Lale Tuna 0000-0003-4409-3459

İbrahim Atakan Geçici 0000-0002-6302-446X

Zeynep Sümeyye Durgun 0000-0003-4335-7803

Ömer Işık 0000-0003-1318-493X

Erken Görünüm Tarihi 27 Eylül 2022
Yayımlanma Tarihi 30 Eylül 2022
Gönderilme Tarihi 18 Mart 2022
Yayımlandığı Sayı Yıl 2022 Cilt: 13 Sayı: 3

Kaynak Göster

APA Güven, O., Tuna, L., Geçici, İ. A., Durgun, Z. S., vd. (2022). ARTERIAL AND VENOUS EMBOLISM DUE TO COVID-19 VACCINE (BIONTECH): CASE SERIES. Journal of Emergency Medicine Case Reports, 13(3), 79-81. https://doi.org/10.33706/jemcr.1089785
AMA Güven O, Tuna L, Geçici İA, Durgun ZS, Işık Ö. ARTERIAL AND VENOUS EMBOLISM DUE TO COVID-19 VACCINE (BIONTECH): CASE SERIES. Journal of Emergency Medicine Case Reports. Eylül 2022;13(3):79-81. doi:10.33706/jemcr.1089785
Chicago Güven, Oya, Lale Tuna, İbrahim Atakan Geçici, Zeynep Sümeyye Durgun, ve Ömer Işık. “ARTERIAL AND VENOUS EMBOLISM DUE TO COVID-19 VACCINE (BIONTECH): CASE SERIES”. Journal of Emergency Medicine Case Reports 13, sy. 3 (Eylül 2022): 79-81. https://doi.org/10.33706/jemcr.1089785.
EndNote Güven O, Tuna L, Geçici İA, Durgun ZS, Işık Ö (01 Eylül 2022) ARTERIAL AND VENOUS EMBOLISM DUE TO COVID-19 VACCINE (BIONTECH): CASE SERIES. Journal of Emergency Medicine Case Reports 13 3 79–81.
IEEE O. Güven, L. Tuna, İ. A. Geçici, Z. S. Durgun, ve Ö. Işık, “ARTERIAL AND VENOUS EMBOLISM DUE TO COVID-19 VACCINE (BIONTECH): CASE SERIES”, Journal of Emergency Medicine Case Reports, c. 13, sy. 3, ss. 79–81, 2022, doi: 10.33706/jemcr.1089785.
ISNAD Güven, Oya vd. “ARTERIAL AND VENOUS EMBOLISM DUE TO COVID-19 VACCINE (BIONTECH): CASE SERIES”. Journal of Emergency Medicine Case Reports 13/3 (Eylül 2022), 79-81. https://doi.org/10.33706/jemcr.1089785.
JAMA Güven O, Tuna L, Geçici İA, Durgun ZS, Işık Ö. ARTERIAL AND VENOUS EMBOLISM DUE TO COVID-19 VACCINE (BIONTECH): CASE SERIES. Journal of Emergency Medicine Case Reports. 2022;13:79–81.
MLA Güven, Oya vd. “ARTERIAL AND VENOUS EMBOLISM DUE TO COVID-19 VACCINE (BIONTECH): CASE SERIES”. Journal of Emergency Medicine Case Reports, c. 13, sy. 3, 2022, ss. 79-81, doi:10.33706/jemcr.1089785.
Vancouver Güven O, Tuna L, Geçici İA, Durgun ZS, Işık Ö. ARTERIAL AND VENOUS EMBOLISM DUE TO COVID-19 VACCINE (BIONTECH): CASE SERIES. Journal of Emergency Medicine Case Reports. 2022;13(3):79-81.